Aim of this paper is to remind the risk of ototoxicity when using chloroquine and hydroxychloroquine, in particular as prophylactic agents against SARS-CoV-2, during the pandemic. Healthy subjects taking chloroquine and hydroxychloroquine as prophylactic agents against SARS-CoV-2, during the pandemic, should be screened periodically, at least by Otoacoustic Emissions (OAEs) in order to detect early manifestations of possible cochlear ototoxic damages.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568171 | PMC |
| http://dx.doi.org/10.1016/j.jgar.2020.09.030 | DOI Listing |
Publication Analysis
Top Keywords
chloroquine hydroxychloroquine
8
hydroxychloroquine prophylactic
8
prophylactic agents
8
agents sars-cov-2
8
sars-cov-2 pandemic
8
ototoxicity prevention
4
prevention sars-cov-2
4
sars-cov-2 covid-19
4
covid-19 emergency
4
emergency aim
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!